SERUM CALCITONIN IN RENAL TRANSPLANT PATIENTS

REFERENCES

• Messa P., Mioni G., Turrin D., Guerra U. P. The Calcitonin-Calcium Relation Curve and Calcitonin Secretory Parameters in Renal Patients with Variable Degrees of Renal Function. Nephrol. Dial. Transplant. 1995; 10: 2259–65
   PubMed Web of Science ®Google Scholar
• Felsenfeld A. J., Machado L., Rodriguez M. The Relationship Between Serum Calcitonin and Calcium in the Hemodialysis Patients. Am. J. Kid. Dis. 1993; 21: 292–299
   PubMed Web of Science ®Google Scholar
• Sekine M., Takami H. Combination of Calcitonin and Pamidronate for Emergency Treatment of Malignant Hypercalcemia. Oncol. Rep. 1998; 5: 197–199
   PubMed Web of Science ®Google Scholar
• Itabashi A. Calcitonin. Nippon Rinsho 1998; 56: 1511–1517
   PubMedGoogle Scholar
• Zaidi M., Bax B. E., Shankar V. S., Moonga B. S., Simon B., Alam A. S., et. al. Dimentional Analysis of Osteoclastic Bone Resorption and the Measurement of Biologically Active Calcitonin. Exp. Physiol. 1994; 79: 387–399
   PubMed Web of Science ®Google Scholar
• Whang K. T., Steinwald P. M., White J. C., Nylen E. S., Snider R. H., Simon G. L., et al. Serum Calcitionin Precursors in Sepsis and Systemic Inflammation. J. Clin. Endocrinol. Metab. 1998; 83: 3296–3301
   PubMed Web of Science ®Google Scholar
• O'Neil W. J., Jordan M. H., Lewis M. S., Snider R. H., Moore C. F., Becker K. L. Serum Calcitonin may be a Marker for Inhalation Injury in Burns. J. Burn. Care Rehab. 1992; 13: 605–616
   PubMedGoogle Scholar
• Canale D. D., Donabedian R. K. Hypercalcitoninemia in Acute Pancreatitis. J. Clin. Endocrinol. Metab. 1975; 40: 738–741
   PubMed Web of Science ®Google Scholar
• Lind L., Ljunghall S. Pronounced Elevation in Circulating Calcitonin in Critical Care Patients is Related to the Severity of Illness and Survival. Inten. Care. Med. 1995; 21: 63–66
   PubMed Web of Science ®Google Scholar
• Ardaillou R., Beaufils M., Nivez M. P., Issac R., Mayaud C., Sraer J. D. Increased Plasma Calcitonin in Early Acute Renal Failure. Clin. Sci. Mol. Med. 1975; 49: 301–304
   PubMedGoogle Scholar
• Giarancini S., Ballada L., Roncari G., Gastaldi L. Calcitonin in Chronic Renal Failure. Nephron 1983; 34: 224–227
   PubMed Web of Science ®Google Scholar
• Simmons R. E., Hjelle J. T., Mahoney C., Deftos L. J., Lister W., Kato P., Babkin R. Renal Metabolism of Calcitonin. Am. J. Physiol. 1988; 23: 593–600
   Google Scholar
• Clark M. B., Williams C. C., Nathanson B. M., Horton R. E., Glass H. I., Foster G. V. Metabolic Fate of Human Calcitonin in the Dog. Endocrinol. 1974; 61: 199–210
   Web of Science ®Google Scholar
• Antonsen J. E., Sherrard D. J., Andress D. L. A Calcimimetic Agent Acutely Suppresses Parathyroid Hormone Levels in Patients with Chronic Renal Failure. Kidney Intern. 1998; 53: 223–227
   PubMed Web of Science ®Google Scholar
• Escalada J., Teruel J. L., Pavon I., Vila T., Navarro J., Varela C. Normal Calcitonin Response to Pentagastrin Stimulation in Patients with Chronic Renal Failure. Acta. Endocrinol. 1993; 129: 39–41
   PubMedGoogle Scholar
• Shieh S. D., Lin Y. F., Lin S. H., Lu K. C. A Prospective Study of Calcium Metabolism in Exertional Heat Stroke with Rhabdomyolysis and Acute Renal Failure. Nehpron 1995; 71: 428–432
   Google Scholar
• Suzuki M., Hirasawa Y., Tanizawa T. Silent and Progressing Accumulation of Aluminum in Bone without Definite Histological Osteomalcic Aspects in Chronic Hemodialysis Patients. Clin. Nephrol. 1995; 44: S51–S55
   Web of Science ®Google Scholar
• Eberhard O. K., Langefeld I., Kuse E. R., Brunkhorst F. M., Kliem V., Schlitt H. J., et al. Procalcitonin in the Early Phase after Renal Transplantation—will It Add to Diagnostic Accuracy. Clin. Transplant. 1998; 12: 206–211
   PubMed Web of Science ®Google Scholar
• Pavlov S. B. Hydrocortisol, Parathyroid, Hormone and Calcitonin in Blood of Patients with Chronic Pyelonephritis and Nephrosclerosis. Klin. Lab. Diagn. 1997; 11: 21–24
   Google Scholar
• Keserer K., Scheuba C., Neuhold N., Weinhausel A., Vierhapper H., Hass O. A., Niederle B. C-cell Hyperplasia and Medullary Thyroid Carcinoma in Patients Routinely Screened for Serum Calcitonin. Am. J. Surg. Pathol. 1998; 22: 722–728
   PubMed Web of Science ®Google Scholar
• Benador N., Siegrist C. A., Gendrel D., Greder C., Benador D., Assicot M., et al. Procalcitonin is a Marker of Severity of Renal Lesions in Pyelonephritis. Pediatrics 1998; 102: 1422–1425
   PubMed Web of Science ®Google Scholar
• Deftos L. J., Weisman M. H., Williams G. W., Karpf D. B., Frumar A. M., Davidson B. J., et al. Influence of Age and Sex on Plasma Calcitonin. N. Eng. J. Med. 1980; 302: 1351–1353
   PubMed Web of Science ®Google Scholar
• Suzuki H. Calcitonin Levels in Normal Individuals with New Highly Sensitive Chemiluminescent Enzyme Immunoassay. J. Clin. Lab. Anal. 1998; 12: 218–222
   PubMed Web of Science ®Google Scholar
• Gomez F., De La Cueva R., Wanters J. Endocrine Abnormalities in Patients Undergoing Long-Term Hemodialysis. Am. J. Med. 1980; 68: 522–530
   PubMed Web of Science ®Google Scholar
• Morrison G., Geheb M. A., Earley L. E. Chronic Renal Failure. The Kidney: Physiology and Pathophysiology, D. W. Seldin, G. Giebisch. Raven Press, New York 1985; 1901–1943
   Google Scholar
• Mujais S. K., Sabatini S., Kurtzman N. A. Pathophysiology of Uremic Syndrome. G. M. Brenner, F. C. Rector. The Kidney, Saunders, Philadelphia 1986; 1587–1930
   Google Scholar
• Szabo A., Sarkozi L., Jaszovszki I. Hormone, Inorganic Phosphate Concentrations and Enzyme Activity in Hemodialysed and Kidney-Transplanted Children. Clin. Physiol. Biochem. 1990; 8: 301–307
   PubMedGoogle Scholar
• Torres A., Rodriguez M., Felsenfeld A., Martin-Malo A., Llach F. Sigmoidal Relationship between Calcitonin and Calcium: Studies in Normal, Parathyroidectomized, and Azotemic Rats. Kidney. Intern. 1991; 40: 700–704
   PubMed Web of Science ®Google Scholar
• Oberbauer R., Banyai S., Schmidt A., Kornek G., Scheithauer W., Mayer G. Serum Tumor Markers after Renal Transplantation. Transplantation 1996; 62: 1506–1509
   PubMed Web of Science ®Google Scholar
• Cecka J. M. Early Rejection: Determining the Fate of Renal Transplants. Transplant Proc. 1991; 23: 1263–1264
   PubMed Web of Science ®Google Scholar
• Sollinger H. W. Mycophenolate Mofetil for the Prevention of Acute Rejection in Primary Cadaveric Renal Allograft Recipients. (U.S. Renal Transplant Mycophenolate Mofetil Study Group). Transplantation 1995; 60: 225–232
   PubMed Web of Science ®Google Scholar
• Wang Y., Wu H., Zhou J. Post-Thyroidectomy Osteoporosis. Chung. Hua. Chung. Liu. Tsa. Chih. 1996; 18: 308–309
   Google Scholar
• Moe S. M. The Treatment of Steroid-Induced Bone Loss in Transplantation. Curr. Opin. Nephrol. Hypertens 1997; 6: 544–549
   PubMed Web of Science ®Google Scholar